Table 1 Training and validation data sets used in paclitaxel neoadjuvant therapy sensitivity prediction experiment in breast cancer patients.

From: In silico Pathway Activation Network Decomposition Analysis (iPANDA) as a method for biomarker development

End point

Training set

Validation set

GEO data sets

Number of samples

GEO data sets

Number of samples

ERN HER2P

GSE20194, GSE20271

38

GSE32636, GSE50948

57

ERN HER2N

GSE20194, GSE20271

108

GSE32646, GSE41998, GSE50948

115

All cancer types

GSE20194, GSE20271

285

GSE22513, GSE32646, GSE41998, GSE50948

299

Back to article page